Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer02:18

Cancer

48.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards optimal valve prescription for transcatheter aortic valve replacement (TAVR) surgery: a machine learning approach.

Health care management science·2026
Same author

Can Artificial Intelligence Improve the Appropriate Use and Decrease the Misuse of REBOA?

Bioengineering (Basel, Switzerland)·2025
Same author

Using Interpretable Artificial Intelligence Algorithms in the Management of Blunt Splenic Trauma: Applications of Optimal Policy Trees as a Treatment Prescription Aid to Improve Patient Mortality.

Bioengineering (Basel, Switzerland)·2025
Same author

Ethics-by-design: efficient, fair and inclusive resource allocation using machine learning.

Journal of law and the biosciences·2022
Same author

Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States.

Proceedings of the National Academy of Sciences of the United States of America·2022
Same author

Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence-Based Model.

JCO clinical cancer informatics·2021
Same journal

Effect of a Multidimensional Digital Health Intervention on Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial.

JCO clinical cancer informatics·2026
Same journal

Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?

JCO clinical cancer informatics·2026
Same journal

Machine Learning Algorithm for the Detection of Tumor Microsatellite Instability Based on Multiomics Biomarkers.

JCO clinical cancer informatics·2026
Same journal

Foundation Model-Driven Regions of Interest Classification and Renaming in Cancer Radiotherapy: A Customizable, Retraining-Free Workflow Across Institutions.

JCO clinical cancer informatics·2026
Same journal

Announcing a New Article Type in <i>JCO Clinical Cancer Informatics</i>: The Resource Report.

JCO clinical cancer informatics·2026
Same journal

A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG Studies.

JCO clinical cancer informatics·2026
See all related articles

Related Experiment Video

Updated: Jul 13, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.0K

Personalized Breast Cancer Screening.

Dimitris Bertsimas1, Yu Ma1, Omid Nohadani2

  • 1Sloan School of Management and Operations Research Center, Massachusetts Institute of Technology, Cambridge, MA.

JCO Clinical Cancer Informatics
|October 16, 2023
PubMed
Summary
This summary is machine-generated.

Personalized cancer screenings using patient data significantly reduce diagnosis delays. This approach improves early detection compared to age-based guidelines, benefiting patient outcomes.

More Related Videos

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.7K
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

14.8K

Related Experiment Videos

Last Updated: Jul 13, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.0K
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
06:03

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis

Published on: February 6, 2020

6.7K
Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

14.8K

Area of Science:

  • Oncology
  • Medical Informatics
  • Machine Learning

Background:

  • Current cancer screening guidelines primarily use patient age, potentially leading to delayed or excessive screenings.
  • Existing systems lack interoperability, hindering the integration of patient data across healthcare providers.
  • Individual medical characteristics are often overlooked in standardized screening protocols.

Purpose of the Study:

  • To develop a clinical support tool using claims data for enhanced physician decision-making in cancer screening.
  • To create a machine learning framework for personalized, dynamic, and data-driven cancer screening recommendations.
  • To address the limitations of age-centric screening by incorporating individual patient data.

Main Methods:

  • Utilized claims data and medical insurance transactions with standardized coding for diagnoses, procedures, and medications.
  • Developed a novel machine learning framework to generate personalized screening recommendations.
  • Applied the methodology to breast cancer mammogram screening using data from 378,840 female patients.

Main Results:

  • Personalized screening demonstrated a statistically significant reduction in average cancer diagnosis delay by 2-3 months across diverse risk populations.
  • Individual patient benefits showed even greater improvements, with delays reduced by up to 10 months.
  • The study highlights the effectiveness of data-driven approaches in optimizing screening timelines.

Conclusions:

  • Integrating personal medical characteristics and machine learning into cancer screening enhances timeliness and adapts to evolving patient risks.
  • The proposed methodology offers a valuable support tool for clinicians, improving screening decisions.
  • Future implementation in healthcare settings can lead to more effective and personalized cancer care pathways.